Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
94.90
0.00 (0.00%)
At close: Jun 1, 2026
Market Cap379.60B +755.0%
Revenue (ttm)84.55B +65.0%
Net Income7.23B +220.7%
EPS1.81 +220.7%
Shares Out 4.00B
PE Ratio52.47
Forward PEn/a
Dividend0.32 (0.34%)
Ex-Dividend DateApr 24, 2026
Volume58,698
Openn/a
Previous Close94.90
Day's Rangen/a
52-Week Range11.10 - 104.00
Beta0.94
Analystsn/a
Price Targetn/a
Earnings DateJul 29, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 195
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements